VERO Stock Overview
A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Venus Concept Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.43 |
| 52 Week High | US$17.49 |
| 52 Week Low | US$2.16 |
| Beta | -0.028 |
| 1 Month Change | -43.62% |
| 3 Month Change | -36.15% |
| 1 Year Change | -67.51% |
| 3 Year Change | -98.28% |
| 5 Year Change | -99.50% |
| Change since IPO | -99.72% |
Recent News & Updates
Shareholder Returns
| VERO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.2% | 0.09% | -0.3% |
| 1Y | -67.5% | 7.7% | 8.1% |
Return vs Industry: VERO underperformed the US Medical Equipment industry which returned 7.7% over the past year.
Return vs Market: VERO underperformed the US Market which returned 8.1% over the past year.
Price Volatility
| VERO volatility | |
|---|---|
| VERO Average Weekly Movement | 68.4% |
| Medical Equipment Industry Average Movement | 9.7% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: VERO's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: VERO's weekly volatility has increased from 39% to 68% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 292 | Rajiv Kanishka De Silva | www.venus.ai |
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system.
Venus Concept Inc. Fundamentals Summary
| VERO fundamental statistics | |
|---|---|
| Market cap | US$2.52m |
| Earnings (TTM) | -US$47.00m |
| Revenue (TTM) | US$64.83m |
0.0x
P/S Ratio-0.1x
P/E RatioIs VERO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VERO income statement (TTM) | |
|---|---|
| Revenue | US$64.83m |
| Cost of Revenue | US$20.53m |
| Gross Profit | US$44.31m |
| Other Expenses | US$91.30m |
| Earnings | -US$47.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 15, 2025
| Earnings per share (EPS) | -45.29 |
| Gross Margin | 68.34% |
| Net Profit Margin | -72.49% |
| Debt/Equity Ratio | 1,399.2% |
How did VERO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 06:09 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Venus Concept Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marie Thibault | BTIG |
| Anthony Vendetti | Maxim Group |
| Suraj Kalia | Oppenheimer & Co. Inc. |